38.30
Mineralys Therapeutics Inc 주식(MLYS)의 최신 뉴스
Will Mineralys Therapeutics Inc. stock remain a Wall Street favoriteWeekly Trading Summary & Fast Gaining Stock Reports - newser.com
Mineralys Therapeutics (NASDAQ: MLYS) sets Q3 results call for 4:30 p.m. ET - Stock Titan
Price action breakdown for Mineralys Therapeutics Inc.Weekly Volume Report & Weekly Breakout Opportunity Watchlist - newser.com
Multi factor analysis applied to Mineralys Therapeutics Inc.July 2025 Summary & Real-Time Market Sentiment Reports - newser.com
Can Mineralys Therapeutics Inc. hit a new high this monthForecast Cut & Low Drawdown Momentum Trade Ideas - newser.com
How Mineralys Therapeutics Inc. stock reacts to Fed rate cutsWeekly Profit Recap & Verified Momentum Watchlists - newser.com
Heatmap analysis for Mineralys Therapeutics Inc. and competitorsWeekly Market Outlook & Weekly Market Pulse Updates - newser.com
Mineralys Therapeutics Inc. stock trendline breakdownJuly 2025 Patterns & Real-Time Volume Trigger Notifications - newser.com
Jennison Associates LLC Sells 743,711 Shares of Mineralys Therapeutics, Inc. $MLYS - MarketBeat
What moving averages say about Mineralys Therapeutics Inc.2025 Market Trends & Verified Trade Idea Suggestions - newser.com
Why Mineralys Therapeutics Inc. stock is favored by top institutionsWatch List & Real-Time Buy Signal Alerts - newser.com
Is Mineralys Therapeutics Inc. stock a dividend growth opportunity2025 Technical Patterns & High Accuracy Swing Entry Alerts - newser.com
Real time scanner hits for Mineralys Therapeutics Inc. explained2025 Year in Review & Real-Time Buy Zone Alerts - newser.com
Has Mineralys Therapeutics Inc. found a price floorQuarterly Earnings Summary & Short-Term High Return Strategies - newser.com
Mineralys Therapeutics (NASDAQ:MLYS) Price Target Raised to $52.00 - MarketBeat
Analysts Conflicted on These Healthcare Names: Bausch Health Companies (BHC), Thermo Fisher (TMO) and Mineralys Therapeutics, Inc. (MLYS) - The Globe and Mail
Will Mineralys Therapeutics Inc. stock maintain growth storyBuy Signal & Community Verified Trade Alerts - newser.com
Mineralys Therapeutics to Present Key Lorundrostat Data at ASN Kidney Week 2025 - MSN
Is Mineralys Therapeutics Inc a good long term investmentMarket Breadth Indicators & Free High Velocity Capital Growth - earlytimes.in
Ranking Mineralys Therapeutics Inc. among high performing stocks via toolsMarket Trend Review & Verified Technical Signals - newser.com
Can machine learning forecast Mineralys Therapeutics Inc. recoveryQuarterly Trade Review & Capital Efficient Trade Techniques - newser.com
Mineralys Therapeutics prices upsized $250M stock offering - MSN
Why Mineralys Therapeutics Stock is Climbing Higher - TipRanks
Mineralys Therapeutics price target raised to $52 from $42 at H.C. Wainwright - TipRanks
HC Wainwright & Co. Maintains Mineralys Therapeutics (MLYS) Buy Recommendation - Nasdaq
Momentum divergence signals in Mineralys Therapeutics Inc. chartWeekly Loss Report & Free Weekly Chart Analysis and Trade Guides - newser.com
Is Mineralys Therapeutics Inc. stock recession proofJuly 2025 Opening Moves & Real-Time Market Sentiment Alerts - newser.com
12,300 Shares in Mineralys Therapeutics, Inc. $MLYS Bought by Allianz Asset Management GmbH - MarketBeat
Is Mineralys Therapeutics Inc. stock a buy in volatile markets2025 Trading Volume Trends & Fast Entry High Yield Tips - Fundação Cultural do Pará
자본화:
|
볼륨(24시간):